In this episode, we dive into the complex world of treating insomnia in patients with major depressive disorder. What's the best approach to help these patients find restful sleep and improve their mood? Join us as we explore a range of strategies, from medication to behavioral interventions. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Treatment Strategies for Managing Insomnia in MDD

Dr. Amit Chopra, a psychiatrist and sleep specialist at Massachusetts General Hospital and Harvard Medical School, delves into innovative pharmacological treatments for insomnia related to major depression. He discusses the intriguing benefits of dual orexin receptor antagonists and melatonin agonists, as well as the effectiveness of low-dose doxepin. Additionally, Chopra explains the pitfalls of traditional therapies and emphasizes integrating cognitive behavioral therapy for optimal patient outcomes.

In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 Is Fish Oil Effective in Youth Depression?

In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia. Faculty: Amit Chopra, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics

In this engaging discussion, Dr. Sydney LeFay, a medical professional specializing in psychiatric care, shares her expertise on prescribing antipsychotics to patients with liver disease. She highlights the critical need for a risk-benefit analysis in complex cases and outlines strategies for safe medication selection. The conversation dives into the types of liver injuries associated with these medications and emphasizes the importance of monitoring liver function. Overall, Dr. LeFay advocates for a collaborative treatment approach to ensure patient safety.

Dr. Amit Chopra discusses the intricate relationship between insomnia and major depressive disorder, highlighting its impact on treatment outcomes and neurobiology. Topics include antidepressants' effects on REM sleep, changes in insomnia definition, and addressing insomnia to prevent depression relapse.

In this episode, we explore the long-term effects of ADHD medication use during pregnancy on children's development. Can continuing treatment pose risks, or is it safer than previously thought? Join us as we dive into a groundbreaking Danish study that sheds light on this critical question. Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 In Utero Exposure to ADHD Medication and Long-Term Offspring Outcomes

Dr. Daniel Clauw discusses the effectiveness of non-pharmacologic therapies like acupuncture, yoga, and cognitive-behavioral therapy in managing fibromyalgia. The podcast explores the integration of these therapies for better outcomes, along with the impact of diet, vitamin D, and small fiber neuropathy on treatment.

In this episode, the editorial team of the Psychopharmacology Institute discusses 3 important topics presented at the APA Annual Meeting: Prescribing psychiatric medications during pregnancy, recent advances in clozapine treatment, and managing eating disorders, namely anorexia nervosa and bulimia nervosa. The episode covers the safety and dose adjustments for medications like SSRIs, lamotrigine, and lithium during pregnancy; early initiation and monitoring of clozapine; and effective treatments, including psychotherapy, olanzapine, and fluoxetine for eating disorders. Hosts: Flavio Guzman, M.D., Paz Badia, M.D., and Lorena Rodriguez, M.D.  

In this episode, we discuss a new study on maternal depression, antidepressant use, and pregnancy complications. Can antidepressants during pregnancy harm the baby? Dr. Lauren Osborne helps us weigh the risks and benefits. Faculty: Lauren Osborne, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 56 Neonatal and Pregnancy Complications Following Maternal Depression or Antidepressant Exposure